Address: 11560 Room A, 14F., No.3, Yuancyu St., Nangang District, Taipei City 11560, Taiwan
Tel: +886 2 2653-5200
Medigen, Inc. is a biotechnology company that specializes in biomedical research and consulting services in the areas of infectious diseases, cancer, and human gene therapy. Our expertise are prostate cancer vaccines and vaccines against emerging and biodefense diseases. We also provide our clients with expert consulting services and contract research in these fields, including experiment design, intellectual property development, and publishing and communicating data to the scientific community and government agencies.
Products and services
Medigen Biotechnology Corp. was founded in Taiwan in 1999, focusing on the development of biopharmaceuticals for liver diseases and cancers. MBC intends to further extending global partnership in new drug development and nucleic acid tests, particularly in the field of oncology and liver diseases. MBC has a paid-in capital of NT$710,000,000 (approximately US$21.5M), and is listed on Emerging market of Taiwan.